PMVP · PMV Pharmaceuticals, Inc. · Analyst Estimates
$1.29
+0.04 (+2.80%)
At close · Oct 28
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Management has determined that the Company's current available cash, cash equivalents and marketable securities may not be sufficient to fund its planned operations for at least one year from the date of this Quarterly Report, and there is substantial doubt as to the Company's ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$66.82M
Shares
53.46M
Volume · Oct 28
113.17K
Avg daily vol (3M)
670.74K
Analyst Estimates
Compare analyst forecasts for PMV Pharmaceuticals, Inc. across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Compiled consensus
These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.
Captured 2026-09-18 07:23 UTC · Publication dates shown per estimate · 8 metric / period groups
FY ending 2026-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-1.42
|
-1.28
|
-1.03
|
3
|
-1.41
|
-1.52
|
-1.52
|
-1.52
|
0
|
0
|
2
|
2
|
|
Revenue
USD
Publication date not stated |
0.00
|
0.00
|
0.00
|
5
|
— | — | — | — | — | — | — | — |
FY ending 2027-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-1.15
|
-0.97
|
-0.61
|
3
|
-1.15
|
-1.09
|
-1.09
|
-1.09
|
0
|
0
|
1
|
1
|
|
Revenue
USD
Publication date not stated |
0.00
|
5.03M
|
12.55M
|
5
|
— | — | — | — | — | — | — | — |
Q ending 2026-09-30
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-0.41
|
-0.34
|
-0.25
|
3
|
-0.39
|
-0.35
|
-0.35
|
-0.35
|
1
|
1
|
1
|
1
|
|
Revenue
USD
Publication date not stated |
0.00
|
0.00
|
0.00
|
4
|
— | — | — | — | — | — | — | — |
Q ending 2026-12-31
| Metric | Low | Average | High | Analyst count | Average, 7 days ago | Average, 30 days ago | Average, 60 days ago | Average, 90 days ago | Estimates lowered, last 7 days | Estimates lowered, last 30 days | Estimates raised, last 7 days | Estimates raised, last 30 days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EPS
USD
Publication date not stated |
-0.36
|
-0.29
|
-0.18
|
3
|
-0.35
|
-0.36
|
-0.36
|
-0.36
|
0
|
0
|
1
|
1
|
|
Revenue
USD
Publication date not stated |
0.00
|
0.00
|
0.00
|
4
|
— | — | — | — | — | — | — | — |